Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment.
Purpose: We evaluated the effect of renal impairment (RI) on the pharmacokinetics of telavancin and hydroxypropylbetadex (excipient in the telavancin drug product). Methods: Adults with normal, mild, moderate or severe RI or end-stage renal disease (ESRD) receiving haemodialysis were included in two...
| Published in: | European Journal of Clinical Pharmacology Vol. 71; no. 6; pp. 707 - 715 |
|---|---|
| Main Authors: | , , |
| Format: | equations & formulas research tables/charts Journal Article |
| Published: |
Springer Nature
Jun2015
|
| Online Access: | View this record in EBSCOhost |